Novolin 70/30 Prefilled Insulin Syringe from Japan
Novolin 70/30 is a pre-mixed human insulin suspension (70% NPH, 30% regular) in disposable 0.3mL, 0.5mL, or 1mL syringes with fixed needles. Provides measured doses for retail diabetic patient use. HTS 3004.31.00.00 includes mixed insulin formulations in therapeutic doses.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Prefilled syringes face stricter sterility validation than pens
• Fixed needle length must be declared—safety engineered sharps rules apply
• Human insulin source (recombinant vs animal) affects documentation requirements